%0 Journal Article %1 boras2021preclinical %A Boras, B. %A Jones, R. M. %A Anson, B. J. %D 2021 %J Nature Communications %K covid-19 pfizermectin %P 6055 %R 10.1038/s41467-021-26239-2 %T Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19. %U https://doi.org/10.1038/s41467-021-26239-2 %V 12

@article{boras2021preclinical, added-at = {2021-12-05T13:57:40.000+0100}, author = {Boras, B. and Jones, R. M. and Anson, B. J.}, biburl = {https://www.bibsonomy.org/bibtex/24d3ea643beead65faf1e3246dd495b2c/fordham1}, description = {Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 | Nature Communications}, doi = {10.1038/s41467-021-26239-2}, interhash = {e7354d3e4383e2c0a017bc2df6eb8489}, intrahash = {4d3ea643beead65faf1e3246dd495b2c}, journal = {Nature Communications}, keywords = {covid-19 pfizermectin}, pages = 6055, timestamp = {2021-12-05T18:14:41.000+0100}, title = {Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19. }, url = {https://doi.org/10.1038/s41467-021-26239-2}, volume = 12, year = 2021 }